NCT01561781View on ClinicalTrials.gov

Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With Vandetanib

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

Digoxin

Oral tablets 0.25mg, single dose

DRUG

Vandetanib

Oral tablets, 300 mg, single dose

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY